Bell Potter names the best ASX shares to buy in March

The broker thinks investors should be snapping up their shares.

| More on:
A young man talks tech on his phone while looking at a laptop. A financial graph is superimposed across the image.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Do you have room in your portfolio for some new ASX shares?

If you do, then it could be worth checking out the two named below that Bell Potter has on its monthly preferred list.

Here's why the broker thinks they are among the best buys on the local market right now:

GUD Holdings Limited (ASX: GUD)

The diversified products company could be an ASX share to buy in March. Bell Potter has been impressed with GUD's performance recently and appears confident that more of the same is coming. Particularly given the resilience of its auto business. It said:

[Its strong result] was driven by the better-than-expected APG performance (the highest-quality business in GUD, in our view) and the improvement in gearing. We see GUD as well-placed to benefit from the ongoing improvement in OEM supply constraints into FY24. Overall, our Buy rating for GUD is predicated on the relative resilience of the legacy auto business and improving momentum in new car sales, which should be favourable for APG's earnings.

Bell Potter has a buy rating and $12.80 price target on the company's shares.

ResMed Inc. (ASX: RMD)

Another ASX share that Bell Potter is bullish on in March is sleep disorder treatment company ResMed. It believes the company still has a very long runway for growth, which could make it a great long term option for investors. It explains:

The market for OSA and chronic obstructive pulmonary disease (COPD) remains under penetrated, and we expect industry volume growth to continue in the 6-8% range for the foreseeable future. In this regard, the competitive dynamics are very much in favour of RMD due to the Philips recall and improving semiconductor availability. […] Furthermore, ResMed is well-positioned to build on its dominant share even after Philips returns to the global market, with the launch of its latest continuous positive airway pressure (CPAP) device, the Air Sense 11.

Bell Potter has a buy rating and $34.00 price target on this ASX share.

Motley Fool contributor James Mickleboro has positions in ResMed. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended ResMed. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Three people in a corporate office pour over a tablet, ready to invest.
Broker Notes

Brokers name 3 ASX shares to buy now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A female stockbroker reviews share price performance in her office with the city shown in the background through her windows
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A woman wearing yellow smiles and drinks coffee while on laptop.
Broker Notes

CBA shares hit new record amid higher revised predictions for home price growth

CBA shares are outperforming the ASX 200 on Tuesday.

Read more »

A man has a surprised and relieved expression on his face. as he raises his hands up to his face in response to the high fluctuations in the Galileo share price today
Broker Notes

Bell Potter says these ASX 200 shares can deliver ~30% returns

Big returns could be on the cards for buyers of these stocks.

Read more »

a man sits at his desk wearing a business shirt and tie and has a hearty laugh at something on his mobile phone.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these shares.

Read more »

A group of young ASX investors sitting around a laptop with an older lady standing behind them explaining how investing works.
Broker Notes

10 ASX shares to buy in FY25

Analysts say investors should buy these stocks in the new financial year.

Read more »

Contented looking man leans back in his chair at his desk and smiles.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

A man has a surprised and relieved expression on his face. as he raises his hands up to his face in response to the high fluctuations in the Galileo share price today
Broker Notes

These ASX shares can rise 25% to 40%

Analysts think these shares could deliver big returns for investors.

Read more »